# Metformin (Immediate Release) *Also known as: Glucophage, Metformin HCl, Metformin hydrochloride, Metformin IR* Bodybuilders discuss metformin to keep blood sugar in check during high-carb bulks or GH use, hoping better insulin sensitivity will help them gain muscle with less fat. The practical questions are whether glucose actually improves, whether digestion suffers, and whether training gains are affected. This entry covers immediate-release tablets. Educational information only — not medical advice. Modelled values are not individual measurements or dosing recommendations. ## Dosage & duration U.S. immediate-release label: adults with type 2 diabetes ### Labeled starting options **Product label** - **Dose:** 500 mg or 850 mg - **How often:** 500 mg twice daily OR 850 mg once daily, with meals - **How long:** Ongoing treatment, reviewed by glucose response and tolerability These are alternative labeled starting schedules. They do not describe a longevity or bodybuilding protocol. - [DailyMed — metformin immediate-release prescribing information (July 2026)](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc466c46-abaa-4675-aef2-4b1a1adfd912) — Sections 1, 2.1, 2.3, 5.1–5.3 and 12.3: type 2 diabetes; adult starting doses; renal assessment, lactic acidosis and B12; nonlinear absorption and plasma versus whole-blood timing. These label timings do not calibrate the selected study curve. The plot’s 500 mg example uses immediate-release study data. ER/XR is a different formulation, and dose changes are not a precise linear exposure conversion. Dose-context sources checked: 2026-10-09. ## At a glance - **Why lifters look at it:** Glucose during a bulk - **Hoped-for payoff:** A leaner bulk Sources or review notes: [1](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc466c46-abaa-4675-aef2-4b1a1adfd912). - **Practical trade-off:** Digestion and training Sources or review notes: [1](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc466c46-abaa-4675-aef2-4b1a1adfd912), [2](https://pubmed.ncbi.nlm.nih.gov/31557380/). **Catalog evidence label (not clinical review):** Human RCT evidence ## Lower glucose does not prove a leaner bulk - **Glucose control:** Glucose and HbA1c trends answer the blood-sugar question. - **Physique progress:** Weight, waist and body composition describe a different outcome. - **Training and digestion:** Workout progress and stomach symptoms matter alongside the lab result. The older-adult training trial does not establish effects in young PED users or a workaround around workouts. Visual sources checked: 2026-10-09. - [DailyMed — metformin immediate-release prescribing information (July 2026)](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc466c46-abaa-4675-aef2-4b1a1adfd912) — Sections 1, 2.1, 2.3, 5.1–5.3 and 12.3: type 2 diabetes; adult starting doses; renal assessment, lactic acidosis and B12; nonlinear absorption and plasma versus whole-blood timing. These label timings do not calibrate the selected study curve. - [Walton et al. 2019 — MASTERS randomized trial](https://pubmed.ncbi.nlm.nih.gov/31557380/) — 94 healthy adults aged at least 65 completed 14 weeks of resistance training with 1700 mg/day metformin or placebo; metformin group gained less lean and thigh muscle mass. This is not a result in young PED users and does not establish an exercise-day workaround. ## Overview ## Why does metformin come up during a bulk? In the bodybuilding discussions reviewed, the goal is to keep glucose under control while eating more carbohydrates, particularly when GH is involved. Some users also hope for better “nutrient partitioning”—more of the gained weight being muscle rather than fat. Those are related motivations, but they are not the same result. ## Does it make a bulk leaner? Metformin has an established glucose-lowering role. A claim that it lets someone eat more without gaining fat is a much bigger step. In reported experiences, food intake, GH, other drugs and training may change together, so a leaner look cannot be assigned to metformin alone. Keep glucose improvement and physique progress as separate questions. ## Will it interfere with gains or workouts? This is a genuine point of disagreement among users: some report no difference, while others mention feeling flatter or training less well. The MASTERS trial found less muscle gain with metformin during resistance training in healthy adults aged 65 and older. It does not answer the question in young enhanced lifters, or prove that moving tablets away from workouts avoids the effect. ## IR, ER and keeping meals comfortable Gas, nausea and diarrhea can matter when eating enough is already difficult. IR and ER release the drug differently, which is why the product matters in both the dose guide and the plot. The visible doses are label context, not a carb-to-metformin formula. Kidney function and B12 remain part of ongoing clinical follow-up. Reduced kidney function increases the risk of serious lactic acidosis. ## Estimated concentration model Immediate-release concentration estimate **Output:** metformin parent: estimated concentration in plasma (mcg/mL). Estimated from study endpoints; the curve between measurements is reconstructed. Immediate-release tablet estimate in healthy adults; it does not represent extended-release metformin or blood glucose. - **Formulation:** Single 500 mg Glucophage immediate-release tablet, Nordic Laboratories (Canada); food state not specified in the accessible study abstract - **Study population:** 24 young healthy volunteers in Caille et al. 1993 - **Route:** Oral Caille 1993 single 500 mg tablet study; the 3.16 h plasma half-life belongs to that study, not the longer whole-blood half-life. - **Calibration dose:** 500 mg - **Reported calibration peak:** 0.6821 mcg/mL - **Peak timing used:** 2.4 hours - **Terminal half-life used:** 3.16 hours - **Reconstructed absorption rate:** 0.7070012 /hour ### Assumptions and limits - Reconstructs first-order absorption from the reported peak, peak time and terminal half-life; this is not the authors’ fitted model. - Input is the nominal metformin hydrochloride tablet strength used by the study. No salt-mass conversion or additional bioavailability factor is applied. - Fixed parameters and linear dose scaling are mathematical approximations. The current label reports less-than-proportional absorption as doses increase. - Repeated-dose superposition uses the same fixed parameters; food, kidney function and transporter interactions are not personalized. - The accessible original abstract reports Cmax, Tmax and half-life but not AUC or meal conditions; total-exposure fit could not be verified against that study. - The reconstructed AUC to infinity is 5.2643 mcg·h/mL at 500 mg. This is a model output, not an observed AUC. - Plasma persistence differs from whole-blood persistence and duration of glucose lowering. This model does not estimate HbA1c, lifespan, exercise adaptations or a safe concentration. ### Model sources - [Caille et al. 1993 — single-dose metformin tablet pharmacokinetics](https://pubmed.ncbi.nlm.nih.gov/8490112/) — Original indexed abstract: 24 young healthy volunteers, single 500 mg Glucophage tablet (Nordic Laboratories, Canada); plasma Cmax 682.1 ng/mL, Tmax 2.4 h, half-life 3.16 h; sampling to 30 h. Food state and AUC were not available in the accessible abstract. DOI 10.1002/bdd.2510140308. - [DailyMed — metformin immediate-release prescribing information (July 2026)](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc466c46-abaa-4675-aef2-4b1a1adfd912) — Sections 1, 2.1, 2.3, 5.1–5.3 and 12.3: type 2 diabetes; adult starting doses; renal assessment, lactic acidosis and B12; nonlinear absorption and plasma versus whole-blood timing. These label timings do not calibrate the selected study curve. **Revision:** metformin-ir-caille-1993-estimate · version 1 ## Sources and review notes Summary source check: 2026-10-09; see source notes 1. This does not certify medical review of the whole page. ### Notes on the quick facts - **Why lifters look at it:** Some lifters consider it for rising fasting glucose, especially alongside GH and high food intake. Source check: 2026-10-09; not a medical review. - **Hoped-for payoff:** Better glucose numbers and gaining less fat are separate outcomes; personal accounts may blur them. Source check: 2026-10-09; not a medical review. - **Practical trade-off:** Stomach symptoms are common; lifters also debate pumps, workout quality and muscle gains. Source check: 2026-10-09; not a medical review. ### References 1. [DailyMed — metformin immediate-release prescribing information (July 2026)](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc466c46-abaa-4675-aef2-4b1a1adfd912) — Sections 1, 2.1, 2.3, 5.1–5.3 and 12.3: type 2 diabetes; adult starting doses; renal assessment, lactic acidosis and B12; nonlinear absorption and plasma versus whole-blood timing. These label timings do not calibrate the selected study curve. 2. [Walton et al. 2019 — MASTERS randomized trial](https://pubmed.ncbi.nlm.nih.gov/31557380/) — 94 healthy adults aged at least 65 completed 14 weeks of resistance training with 1700 mg/day metformin or placebo; metformin group gained less lean and thigh muscle mass. This is not a result in young PED users and does not establish an exercise-day workaround. 3. [Caille et al. 1993 — single-dose metformin tablet pharmacokinetics](https://pubmed.ncbi.nlm.nih.gov/8490112/) — Original indexed abstract: 24 young healthy volunteers, single 500 mg Glucophage tablet (Nordic Laboratories, Canada); plasma Cmax 682.1 ng/mL, Tmax 2.4 h, half-life 3.16 h; sampling to 30 h. Food state and AUC were not available in the accessible abstract. DOI 10.1002/bdd.2510140308. 4. [DailyMed — metformin extended-release tablet label](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdd3481c-aaec-47ac-9790-01de68b2e253) — Formulation comparison only: matrix extended-release tablets, usual starting dose 500 mg with the evening meal, median Tmax 7 h (4–8 h). Not the plotted formulation. --- **Canonical URL:** https://anabolicplotter.com/compounds/metformin/ **Methodology:** https://anabolicplotter.com/methodology/ **Plot:** https://anabolicplotter.com/plot?compound=metformin